Keryx Biopharmaceuticals Inc (KERX.PH) Analysts | Reuters.com
Edition:
United States

Keryx Biopharmaceuticals Inc (KERX.PH)

KERX.PH on Philadelphia Stock Exchange

5.86USD
24 Jun 2016
Change (% chg)

$-0.32 (-5.25%)
Prev Close
$6.19
Open
$5.78
Day's High
$6.13
Day's Low
$5.76
Volume
36,444
Avg. Vol
10,574
52-wk High
$10.46
52-wk Low
$2.82

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.28 December 27 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 3 3 3 3
(3) HOLD 3 3 3 3
(4) UNDERPERFORM 0 0 0 0
(5) SELL 1 2 2 2
No Opinion 0 0 0 0
Mean Rating 2.18 2.42 2.42 2.42

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 9 8.51 9.07 7.71 17.64
Quarter Ending Sep-16 9 10.38 11.22 9.07 18.36
Year Ending Dec-16 10 39.20 42.76 36.60 110.54
Year Ending Dec-17 9 94.16 177.80 55.31 280.00
Earnings (per share)
Quarter Ending Jun-16 10 -0.28 -0.15 -0.38 -0.06
Quarter Ending Sep-16 10 -0.17 -0.12 -0.21 -0.03
Year Ending Dec-16 11 -0.96 -0.66 -1.16 -0.37
Year Ending Dec-17 10 -0.29 0.20 -0.56 1.09

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 6.64 6.82 0.19 2.81
Quarter Ending Dec-15 5.75 5.78 0.04 0.65
Quarter Ending Jun-15 2.86 2.51 0.35 12.09
Quarter Ending Mar-15 2.45 1.17 1.28 52.06
Quarter Ending Dec-14 1.23 0.57 0.66 53.70
Earnings (per share)
Quarter Ending Mar-16 -0.26 -0.39 0.13 -52.64
Quarter Ending Dec-15 -0.25 -0.36 0.11 -42.29
Quarter Ending Sep-15 -0.25 -0.29 0.04 -16.42
Quarter Ending Jun-15 -0.26 -0.26 0.00 -0.85
Quarter Ending Mar-15 -0.30 -0.28 0.02 -5.72

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 8.51 8.51 8.51 8.37 17.64
Quarter Ending Sep-16 10.38 10.38 10.42 10.55 18.36
Year Ending Dec-16 39.20 39.20 39.32 39.29 110.54
Year Ending Dec-17 94.16 94.16 90.47 89.22 280.00
Earnings (per share)
Quarter Ending Jun-16 -0.28 -0.28 -0.27 -0.23 -0.06
Quarter Ending Sep-16 -0.17 -0.17 -0.17 -0.17 -0.03
Year Ending Dec-16 -0.96 -0.96 -0.96 -0.77 -0.37
Year Ending Dec-17 -0.29 -0.29 -0.31 -0.31 1.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 0 0 0 0
Quarter Ending Sep-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0
Earnings
Quarter Ending Jun-16 0 0 0 0
Quarter Ending Sep-16 0 0 0 0
Year Ending Dec-16 0 0 0 0
Year Ending Dec-17 0 0 0 0

Analyst Research Reports

Report Title Price
Provider : New Constructs, LLC
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.